Description
The DST (Dementia Screening Test) is the only dementia test which is a medical device as per regulatory requirements. The DST very effectively detects early dementia risks, and can reliably distinguish between the different dementia risk levels. It is therefore suitable for dementia screening, as well as for risk severity monitoring / therapy control over time.
Additional functions include:
- a reminder to redo the test after 3-6 months, for medical monitoring
- continued engagement for prevention, through regular Dementia News
- tracking of the dementia risk over time, visualized in a graphic
- option to e-mail and/or print the test results (e.g., for documentation purposes)
To date, there is no effective treatment for advanced dementia stages. Therefore, effective screening is essential to begin treatment before the brain damages become irreversible. Because for early dementia stages, there are already effective treatment options that can significantly delay or even prevent disease progression.
With special tests, dementia risks can be detected 18 years and more prior to the first symptoms. The Dementia Screening Test (DST) is the only such test which is a Medical Device for dementia screening as per the regulatory requirements.
The good news is: for most people the test can give the all-clear!
The DST in short:
- Easy to perform, also for medical laypersons.
- Reliable: more than 96% sensitivity of the algorithm shown in clinical trials, probably the highest value worldwide for such tests.
- Safe: no registration required, no storage of personal data, works without internet connection, no advertising.
- Medical Device as per regulatory requirements.
- Works with all dementia subtypes (Alzheimer's dementia, vascular dementia, fronto-temporal dementia, Lewy-body dementia, secondary dementia, hybrids / other forms).
- Engaging: provides you with the latest research results on a regular basis, and reminds to retake the test regularly.
- Documents changes in dementia risk over time.
- Supports research and public awareness for dementia patients and relatives.
The DST as such, like any medical test, does not provide or replace a diagnosis. Therefore, please seek a doctor’s advice in addition to using this app and before making any medical decisions.
Take the test now, and become a superager!
Hide
Show More...
Additional functions include:
- a reminder to redo the test after 3-6 months, for medical monitoring
- continued engagement for prevention, through regular Dementia News
- tracking of the dementia risk over time, visualized in a graphic
- option to e-mail and/or print the test results (e.g., for documentation purposes)
To date, there is no effective treatment for advanced dementia stages. Therefore, effective screening is essential to begin treatment before the brain damages become irreversible. Because for early dementia stages, there are already effective treatment options that can significantly delay or even prevent disease progression.
With special tests, dementia risks can be detected 18 years and more prior to the first symptoms. The Dementia Screening Test (DST) is the only such test which is a Medical Device for dementia screening as per the regulatory requirements.
The good news is: for most people the test can give the all-clear!
The DST in short:
- Easy to perform, also for medical laypersons.
- Reliable: more than 96% sensitivity of the algorithm shown in clinical trials, probably the highest value worldwide for such tests.
- Safe: no registration required, no storage of personal data, works without internet connection, no advertising.
- Medical Device as per regulatory requirements.
- Works with all dementia subtypes (Alzheimer's dementia, vascular dementia, fronto-temporal dementia, Lewy-body dementia, secondary dementia, hybrids / other forms).
- Engaging: provides you with the latest research results on a regular basis, and reminds to retake the test regularly.
- Documents changes in dementia risk over time.
- Supports research and public awareness for dementia patients and relatives.
The DST as such, like any medical test, does not provide or replace a diagnosis. Therefore, please seek a doctor’s advice in addition to using this app and before making any medical decisions.
Take the test now, and become a superager!
Screenshots
User Rating
App is not rated in Poland yet.
Ratings History
DST Installs
Last 30 days
DST Revenue
Last 30 daysDST Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
24
|
|
Top Paid
|
|
69
|
|
Top Paid
|
|
199
|
|
Top Paid
|
|
201
|
|
Top Paid
|
|
216
|
Keywords
DST Competitors
| Name | Reviews | Recent release | |
|---|---|---|---|
Alzheimer&YOU Aktiv im Alltag
|
0
|
1 month ago | |
CardioSecur Active
Your mobile ECG
|
0
|
2 years ago | |
Parkinson's Cognitive Research
Studies about Parkinson's
|
0
|
2 weeks ago | |
Psoriasis App | Sorea
Smart & holistic help
|
0
|
4 months ago | |
Apollo - Cognitive Testing
|
0
|
1 year ago | |
HeadApp
Cognitive Therapy
|
0
|
4 months ago | |
neotivTrials
Research with us
|
0
|
1 week ago | |
Clock Drawing Test
Quick Dementia Screening
|
0
|
1 year ago | |
IGNITE App
Cognitive assessment tool
|
0
|
2 years ago | |
DemenzGuide
|
0
|
6 months ago |
DST Revenue and Downloads
Gain valuable insights into DST performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Sebastian Dr. Horn
- Languages
- English
- Recent release
- 2.6 (2 months ago )
- Released on
- Dec 28, 2018 (5 years ago )
- Also available in
- Germany, United Kingdom, Switzerland, South Africa, Romania, Canada, United States, Austria, Pakistan, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, India, Peru, Philippines, Taiwan, Poland, Portugal, Russia, Vietnam, Saudi Arabia, Sweden, Singapore, Thailand, Ukraine, Türkiye, Ecuador, Argentina, Australia, Azerbaijan, Belgium, Brazil, Belarus, Chile, China, Colombia, Czechia, Denmark, Dominican Republic, South Korea, Egypt, Spain, Finland, France, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, United Arab Emirates, Italy
- Last Updated
- 6 days ago